resveratrol has been researched along with Respiratory Syncytial Virus Infections in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Di Pietro, M; Filardo, S; Mastromarino, P; Sessa, R | 1 |
Deng, Y; Li, S; Li, W; Liu, E; Liu, T; Long, X; Ren, L; Tan, B; Tu, W; Wang, L; Xie, X; Zang, N; Zhao, X; Zhou, L; Zhou, N | 1 |
Cheng, K; Gao, B; Wu, Z; Xu, J | 1 |
Deng, Y; Fu, Z; Li, S; Li, W; Liu, E; Long, X; Ren, L; Xie, J; Xie, X; Xu, F; Zang, N | 1 |
Deng, Y; Li, S; Liu, E; Luo, Y; Ni, K; Peng, C; Wang, L; Wu, S; Xie, X; Zang, N | 1 |
Deng, Y; He, Y; Li, SM; Liu, EM; Wang, LJ; Xie, XH; Yang, XQ; Zang, N | 1 |
Ding, G; Huang, S; Liu, B; Wang, W; Wang, Y; Yang, T; Yuan, Y; Zhang, A; Zhang, P; Zhu, C | 1 |
Dai, Q; Li, J; Peng, L; Sun, H; Wang, S; Xu, J; Xu, S | 1 |
1 review(s) available for resveratrol and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Therapeutic potential of resveratrol against emerging respiratory viral infections.
Topics: Antiviral Agents; Betacoronavirus; Communicable Diseases, Emerging; Coronavirus Infections; COVID-19; Humans; Influenza, Human; Pandemics; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Resveratrol; SARS-CoV-2; Virus Diseases | 2020 |
7 other study(ies) available for resveratrol and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Resveratrol inhibits the TRIF-dependent pathway by upregulating sterile alpha and armadillo motif protein, contributing to anti-inflammatory effects after respiratory syncytial virus infection.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Armadillo Domain Proteins; Cytoskeletal Proteins; Down-Regulation; Female; Humans; Lung; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Resveratrol; Signal Transduction; Stilbenes; Up-Regulation | 2014 |
Analysis of influence of baicalin joint resveratrol retention enema on the TNF-α, SIgA, IL-2, IFN-γ of rats with respiratory syncytial virus infection.
Topics: Animals; Antiviral Agents; Cell Line; Drug Interactions; Enema; Female; Flavonoids; Humans; Immunoglobulin A, Secretory; Interferon-gamma; Interleukin-2; Male; Rats; Rats, Sprague-Dawley; Respiratory Syncytial Virus Infections; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2014 |
Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain-Derived Neurotrophic Factor; Bronchoalveolar Lavage Fluid; Female; Interferon-gamma; Lung; Mice; Mice, Inbred BALB C; Nerve Growth Factor; Pneumonia; Respiratory Function Tests; Respiratory Hypersensitivity; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Resveratrol; RNA, Viral; Stilbenes | 2015 |
Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchoalveolar Lavage Fluid; Female; Gene Expression Profiling; Inflammation; Interferon-gamma; Lung; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Resveratrol; Signal Transduction; Stilbenes; Toll-Like Receptor 3; Viral Load | 2011 |
Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells.
Topics: Adaptor Proteins, Vesicular Transport; Antiviral Agents; Cell Line; Dexamethasone; Down-Regulation; Epithelial Cells; Humans; Interleukin-6; Interleukin-8; Protein Serine-Threonine Kinases; Respiratory Mucosa; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Respiratory System; Resveratrol; Ribavirin; Stilbenes; Virus Replication | 2012 |
Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.
Topics: Aldosterone; Animals; Apoptosis; Cell Line; Cytoprotection; Disease Models, Animal; Enzyme Activation; Gene Expression Regulation; Genes, Reporter; Kidney Diseases; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Mitochondria; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Podocytes; Promoter Regions, Genetic; Receptors, Mineralocorticoid; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Resveratrol; RNA Interference; Sirtuin 1; Stilbenes; Time Factors; Trans-Activators; Transcription Factors; Transfection | 2012 |
[Regulation trend of resveratrol on TNFα-,IL-1β, IL-6 expressions in bronchoalveolar lavage fluid of RSV-infected BALB/c mice].
Topics: Animals; Bronchoalveolar Lavage Fluid; Female; Interleukin-1beta; Interleukin-6; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Resveratrol; Stilbenes; Tumor Necrosis Factor-alpha | 2012 |